Opinion/decision on a Paediatric investigation plan (PIP): Enerzair Breezhaler, Indacaterol (acetate),mometasone (furoate),glycopyrronium bromide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Respirat

Opinion/decision on a Paediatric investigation plan (PIP): Enerzair Breezhaler, Indacaterol (acetate),mometasone (furoate),glycopyrronium bromide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Respiratory, thoracic and mediastinal disorders, PIP number: EMA/PE/0000244179